Neuroimmune Foundation is a 501(c)(3) non-profit organization dedicated to
  • dramatically accelerating physician education of immunopsychiatric conditions
  • significantly improving outcomes for individuals impacted by these disorders through prompt diagnosis and insurance based care
  • providing meaningful support to families during their darkest days
  • catalyzing research at an unprecedented pace that will ultimately lead to lasting remission for all individuals impacted by these disorders.
Join us for a two day conference via webinar!

Inflamma­tory Brain Disorders Conference 2025

The 2025 Inflammatory Brain Disorders Conference is hosted by Neuroimmune Institute, in partnership with Neuroimmune Foundation and with our Stanford and UCSF collaborators. Neuroimmune Institute was founded with the goal of rapidly advancing clinical medicine and research focused on immunopsychiatric, neuroimmune, and inflammatory brain conditions as well as autism.

Neuroimmune Institute offers continuing medical education on a broad array of topics beyond the scope of Neuroimmune Foundation’s mission.

New CME opportunity

Psychiatric Presentations with a Neuroimmune Basis ECHO

The Inflammatory Brain Disorders Conference features nationally and internationally renowned experts skilled in diagnostic and therapeutic approaches who will present a diverse range of emerging clinical and research challenges, insights, and advances in the field of inflammatory brain disorders. Presentations are carefully selected to familiarize attendees with rapidly developing research and to educate clinicians on the latest understanding of treatment options.

What are Inflammatory Brain Disorders?

Individuals with inflammatory brain conditions often present with prominent neuropsychiatric symptoms that can be confusing for physicians and families alike. Our CME events feature nationally and internationally renowned experts skilled in diagnostic and therapeutic approaches who present a diverse range of emerging clinical and research challenges, insights, and advances in the field of inflammatory brain disorders. Presentations are carefully selected to familiarize attendees with rapidly developing research and to educate clinicians on the latest understanding of treatment options.

Check out our

Extensive Free Resources

Our extensive free resources for clinicians include Continuing Medical Education, access to top experts in the field through monthly case consultations, and quarterly compilation of relevant research. We provide clinicians the tools to confidently diagnose and treat immune-mediated neuropsychiatric illnesses and inflammatory brain conditions. Our Circle of Clinicians helps families to find a physician. Families are supported through therapist, physician, and researcher led webinars, local support meetings in locations around the world, a private Facebook group, and other resources.

Advocating on Behalf of Individuals with Neuroimmune and Inflammatory Brain Conditions

About us

Neuroimmune FoundationTogether with our supporters, Neuroimmune Foundation is making huge strides in educating clinicians on how to diagnose and treat immune and inflammation driven causes of psychiatric deteriorations. Visit our Impact Report pages to learn how our CME and related events help physicians gain confidence treating PANS, PANDAS, encephalitis, and related conditions.

Sign up for our newsletter

  • (All fields required)

Research Roundup

  • Pediatric Post-infectious Neuroinflammatory Syndromes Come to the Fore

    Karger Developmental Neuroscience
    April 26, 2025

  • Immunological Drivers and Potential Novel Drug Targets for Major Psychiatric, Neurodevelopmental, and Neurodegenerative Conditions

    Nature | Molecular Psychiatry
    April 25, 2025

  • Defining Clinical Course of Patients Evaluated for Pediatric Acute-Onset Neuropsychiatric Syndrome: Phenotypic Classification Based on 10 Years of Clinical Data

    Karger Developmental Neuroscience
    April 4, 2025

  • New-onset OCD and juvenile enthesitis related arthritis after COVID-19 (Three Cases)

    Karger Developmental Neuroscience
    April 2, 2025

  • Acute Onset Neuropsychiatric Conditions in Children and Adolescents following SARS-CoV-2 Infection: A Case Series

    Karger Developmental Neuroscience
    March 24, 2025

  • Obsessive-Compulsive Disorder Associated with Autoimmunity in Youth: Clinical Course Before and After Rituximab +/− Adjunctive Immunomodulation

    Karger Developmental Neuroscience
    March 10, 2025

  • Eight Cases of Pediatric Acute-Onset Neuropsychiatric Syndrome with Inflammatory Bowel Disease: Immunologic Intersections

    Karger Developmental Neuroscience
    February 10, 2025

  • Naproxen Adjunct to Fluoxetine for Moderate-to-severe Obsessive-compulsive Disorder: A Randomized, Double-blind, Placebo-controlled Trial

    Psychiatry and Clinical Neurosciences / Wiley
    October 1, 2024

  • IVIG Response in Pediatric Acute-onset Neuropsychiatric Syndrome Correlates with Reduction in Pro-inflammatory Monocytes and Neuropsychiatric Measures

    Frontiers in Immunology
    October 3, 2024